The fund is constantly included in less than 2 investment rounds annually. When the investment is from Technium Partners the average startup value is 10-50 millions dollars. The high activity for fund was in 2018. The usual things for fund are deals in the range of 1 - 5 millions dollars.
We can highlight the next thriving fund investment areas, such as Therapeutics, Biotechnology. Among the most popular portfolio startups of the fund, we may highlight Immusoft.
The usual cause for the fund is to invest in rounds with 4 partakers. Despite the Technium Partners, startups are often financed by Westcott LLC, The Thiel Foundation, Founders Fund. The meaningful sponsors for the fund in investment in the same round are Tim Draper, Peter Thiel, Invariantes Fund. In the next rounds fund is usually obtained by Tim Draper, RBV Capital, Peter Thiel.
Related Funds
| Fund Name | Location |
| Beijing Youth Daily | Beijing, Beijing, China |
| Brookfield Asset Management | Canada, Ontario, Toronto |
| Discovery Capital fund | - |
| DP Invest | - |
| Harvest Capital | Beijing, Beijing, China |
| Legions Holdings Group | Beijing, Beijing, China |
| Neva SGR | Italy, Piemont, Turin |
| Prescient Capital | Gurgaon, Haryana, India |
| Scient Capital | California, Sunnyvale, United States |
| XPT Fund | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Immusoft | $3M | 05 Jan 2018 | United States, Seattle | ||
Immusoft | $2M | 07 Nov 2016 | United States, Seattle |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Immusoft | $3M | 05 Jan 2018 | United States, Seattle | ||
Immusoft | $2M | 07 Nov 2016 | United States, Seattle |
